Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H42Cl3N3O2 |
InChIKeyYZAARVFETYRKAV-IEVBDCQASA-N |
CAS Registry2459230-82-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 13 Jan 2020 |